NFKB1 and cancer: friend or foe?

J Concetti, CL Wilson - Cells, 2018 - mdpi.com
Current evidence strongly suggests that aberrant activation of the NF-κB signalling pathway
is associated with carcinogenesis. A number of key cellular processes are governed by the …

Nuclear factor-kappaB in autoimmunity: man and mouse

B Miraghazadeh, MC Cook - Frontiers in immunology, 2018 - frontiersin.org
NF-κB (nuclear factor-kappa B) is a transcription complex crucial for host defense mediated
by innate and adaptive immunity, where canonical NF-κB signaling, mediated by nuclear …

Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes

M Kaustio, E Haapaniemi, H Göös, T Hautala… - Journal of Allergy and …, 2017 - Elsevier
Background The nuclear factor κ light-chain enhancer of activated B cells (NF-κB) signaling
pathway is a key regulator of immune responses. Accordingly, mutations in several NF-κB …

Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis

K Bogunia-Kubik, B Wysoczańska, D Piątek… - Archivum immunologiae …, 2016 - Springer
Abstract MicroRNA-146a (miR-146a) has been shown to play an important role in the
regulation of inflammatory innate immune responses, and found to be differentially …

Pannexin 1 binds β-catenin to modulate melanoma cell growth and metabolism

S Sayedyahossein, K Huang, Z Li, C Zhang… - Journal of Biological …, 2021 - ASBMB
Melanoma is the most aggressive skin malignancy with increasing incidence worldwide.
Pannexin1 (PANX1), a member of the pannexin family of channel-forming glycoproteins …

[PDF][PDF] Behçet's syndrome: a critical digest of the 2014-2015 literature

G Hatemi, E Seyahi, I Fresko, R Talarico… - Clin Exp …, 2015 - clinexprheumatol.org
Several studies were published last year which focused on the epidemiology,
immunopathogenesis, genetics, clinical manifestations and management of Behçet's …

Understanding Behçet's disease in the context of innate immunity activation

SF Perazzio, LEC Andrade, AWS De Souza - Frontiers in immunology, 2020 - frontiersin.org
Behçet´ s disease (BD) is a heterogeneous condition consisting of idiopathic systemic
vasculitis affecting large and small blood vessels of different types (ie, arteries, veins, or …

Behçet disease (BD) and BD‐like clinical phenotypes: NF‐κB pathway in mucosal ulcerating diseases

SF Perazzio, EJ Allenspach, KK Eklund… - Scandinavian …, 2020 - Wiley Online Library
Behçet's disease (BD) is a heterogeneous multi‐organ disorder in search of a unified
pathophysiological theory and classification. The disease frequently has overlapping …

Paediatric Behçet's disease: a comprehensive review with an emphasis on monogenic mimics

O Kul Cinar, M Romano, F Guzel, PA Brogan… - Journal of Clinical …, 2022 - mdpi.com
Behçet's disease (BD) is a polygenic condition with a complex immunopathogenetic
background and challenging diagnostic and therapeutic concepts. Advances in genomic …

Association of pre-miRNA-499 rs3746444 and pre-miRNA-146a rs2910164 polymorphisms and susceptibility to Behcet's disease

T Oner, G Yenmis, K Tombulturk, C Cam… - Genetic Testing and …, 2015 - liebertpub.com
MiRNAs and NFKB1 are well-known immune response and inflammation regulators. MiRNA
gene polymorphisms may affect miRNA biogenesis and function and, may thus, lead to …